期刊文献+

重组干扰质粒对卵巢癌COC1细胞HDAC1表达的影响

Interference recombinant plasmids targeting HDAC1 gene in ovarian cancer cell COC1
下载PDF
导出
摘要 目的构建重组HDAC1基因的短发夹RNA(shRNA)慢病毒干扰质粒并研究其对卵巢癌COC1细胞HDAC1表达的影响。方法针对HDAC1基因设计特异性siRNA靶点,构建慢病毒干扰质粒载体,筛选获得的有效shRNA慢病毒干扰序列,将其转染卵巢癌COC1细胞。采用Real-time PCR方法检测靶基因在mRNA水平的沉默效果,Western blot方法检测靶基因在蛋白质水平的沉默效果。结果构建的慢病毒载体shRNA的PCR鉴定和测序正确。shRNA慢病毒干扰质粒转染COC1细胞后HDAC1基因的mRNA表达量和蛋白质水平较阴性对照质粒转染组均显著下调(P<0.05)。结论成功构建HDAC1基因的shRNA慢病毒干扰质粒,该慢病毒干扰质粒能够在细胞水平有效沉默靶基因。 Objective To construct the shRNA lentiviral plasmid targeting HDAC1 gene and detect its effect of gene silence in COC1 cells.Methods The specific siRNA sequences targeting HDAC1 gene were cloned into pRNAT-U6.2/Lenti lentiviral plasmid.After screening for the valid siRNA,HDAC1 specific shRNA was transfectted into COC1 cells.Then,real-time PCR and Western Blot was performed to determine the expression level of HDAC1.ResultsPCR and sequencing results revealed that shRNA plasmids were correctly constructed.The HDAC1 expressions in COC1 cells were down regulated at mRNA and protein level by plasmid transfection.The expression of HDAC1 was decreased in mRNA levels and protein compared with negative control.Conclusion The recombinant lentiviral shRNA plasmid targeting HDAC1 gene has been successfully constructed.HDAC1 mRNA and protein can be down-regulated availably in COC1 cells.
作者 贾妍 邹颖刚 许天敏 崔满华 JIA Yan ZOU Ying-gang XU Tian-min et al.(Department of Obstetrics and Gynecology, Second Hospital of Jilin University ,Changchun 130041, China)
出处 《中国实验诊断学》 2016年第10期1615-1618,共4页 Chinese Journal of Laboratory Diagnosis
基金 吉林省科技厅青年科研基金(201201034)
关键词 HDAC1 短发夹RNA 慢病毒 HDAC1 short hairpin RNA lentivirus
  • 相关文献

参考文献3

二级参考文献32

  • 1Jones PA, Martienssen R. A blueprint for a human epigenome project : the AACR human epigenome workshop[J]. Cancer Res, 2005, 65(24) :11241-11246.
  • 2Marks P, Rifkind RA, Riehon VM, et al. Histone deacetylases and cancer: causes and therapies[J]. Nat Rev Cancer, 2001, 1(3) : 194-202.
  • 3Halkidou K, Gaughan L, Cook S, et al. Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer[J].Prostate, 2004, 59(2) :177-189.
  • 4Wilson AJ, Byun DS, Popova N, et al. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer[J]. J Biol Chem, 2006, 281(19): 13548-13558.
  • 5Johnstone RW. Histone-deacetylase inhibitors: novel drugs for the treatment of eancer[J]. Nat Rev Drug Discov, 2002, 1(4) :287-299.
  • 6Richon VM, Zhou X, Rifldnd RA, et al. Histone deacetylase inhibitors: development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers[J]. Blood Cells Mol Dis, 2001, 27(1):260 264.
  • 7Glaser KB, Stayer MJ, Waring JF, et al. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA earcinoma cell lines[J]. Mol Cancer Ther, 2003, 2(2) : 151-163.
  • 8Bemstein BE, Tong JK, Schreiber SL. Genomewide studies of histone deacetylase function in yeast[J]. Proc Natl Acad Sci U S A, 2000, 97(25) :13708-13713.
  • 9Krajewski S, Kraiewska M, Shabaik A, et al. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2[J]. Am H Pathol, 1994, 145(6) :1323-1336.
  • 10Baldi A, Groeger AM, Esposito V, et al. Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival[J]. Thorax, 2002, 57(4) :353-356.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部